Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study of FMT in Patients With AML Allo HSCT in Recipients [Phase 2]
Phase 2 trial evaluating fecal microbiota transplantation in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell t…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 clinical trial evaluating HYML-122 for FLT3-positive relapsed or refractory acute myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML [Phase 2]
Phase 2 clinical trial update comparing low-dose azacitidine with pioglitazone and all-trans retinoic acid versus standard-dose azacitidine …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia
The completed clinical trial analyzes CMTM6 expression in adults with acute myeloid leukemia to evaluate its potential as a biomarker.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) [Phase 2]
This Phase 2 clinical trial update reports on conditioning with benadamustine, fludarabine, and busulfan (FluBuBe) for recipients of haploid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Study of LAM-003 in Patients With Acute Myeloid Leukemia [Phase 1]
This Phase 1 study of LAM-003 in patients with acute myeloid leukemia has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers [Phase 2]
A Phase 2 clinical trial update on haploidentical stem cell transplantation for multiple hematologic cancers, with the study status reported…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 1]
Phase 1 study of KHK2823 in Acute myeloid leukemia and myelodysplastic syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients [Phase 2]
A Phase 2 study evaluating azacitidine, venetoclax, and flumatinib in newly diagnosed Ph-positive acute leukemia and CML-AP/BP; the trial ha…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002) [Phase 1]
An early-phase study evaluating KW-2449 in patients with acute myeloid leukemia reports on safety, tolerability, and pharmacokinetic/pharmac…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation [EARLY_Phase 1]
A phase 1 pilot trial evaluating pembrolizumab for relapse after allogeneic stem cell transplantation in patients with classical Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors [Phase 2, Phase 3]
Phase 2/3 trial comparing family-mismatched/haploidentical donors to matched unrelated donors in acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy [Phase 2]
Phase II trial evaluating the MEGO combination (mitoxantrone, etoposide, gemtuzumab ozogamicin) in acute myeloid leukemia patients refractor…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia [Phase 3]
Phase 3 trial update for dociparstat in combination with standard chemotherapy in acute myeloid leukemia; study terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating TJ011133 as monotherapy and in combination with azacitidine in AML or MDS has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 3]
Phase 3 clinical trial evaluating MA+AZA regimen for newly diagnosed acute myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial [Phase 2, Phase 3]
Clinical trial update for IDEAL trial evaluating innate donor effector allogeneic lymphocyte infusion after stem cell transplantation in AML…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia [Phase 2]
Phase 2 clinical trial investigating venetoclax in combination with fludarabine, cytarabine, and idarubicin (also known as FLAG-IDA) for ind…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: VA vs DA for Newly Diagnosed Hig-risk AML [Phase 2, Phase 3]
A clinical trial comparing VA versus DA for newly diagnosed high-risk acute myeloid leukemia is in Phase 2 and Phase 3 and currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Pilot RCT of the PRISM Intervention for AYAs With Cancer [Phase 2]
pilot randomized Phase 2 trial evaluating the PRISM intervention for adolescents and young adults with cancer, completed.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia [Phase 2]
Phase 2 trial update evaluating topotecan hydrochloride and carboplatin with or without veliparib for advanced myeloproliferative disorders …
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer [Phase 2]
Phase 2 study evaluating a conditioning regimen of fludarabine phosphate, cyclophosphamide, and total body irradiation followed by donor ste…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial update reporting results for APR-246 in combination with azacitidine for TP53-mutated acute myeloid leukemia or myelo…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients [Phase 1, Phase 2]
The Phase 1/2 trial evaluating crenolanib in combination with chemotherapy for FLT3-mutated acute myeloid leukemia has completed enrollment …
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating BI 836858 with decitabine in adults with acute myeloid leukemia has completed, with results posted in …